GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » FCF Margin %

Thyrocare Technologies (NSE:THYROCARE) FCF Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Thyrocare Technologies's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Thyrocare Technologies's Revenue for the three months ended in Mar. 2024 was ₹1,543 Mil. Therefore, Thyrocare Technologies's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Thyrocare Technologies's current FCF Yield % is 3.26%.

The historical rank and industry rank for Thyrocare Technologies's FCF Margin % or its related term are showing as below:

NSE:THYROCARE' s FCF Margin % Range Over the Past 10 Years
Min: 12.83   Med: 17.64   Max: 36.38
Current: 18.54


During the past 10 years, the highest FCF Margin % of Thyrocare Technologies was 36.38%. The lowest was 12.83%. And the median was 17.64%.

NSE:THYROCARE's FCF Margin % is ranked better than
89.19% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs NSE:THYROCARE: 18.54


Thyrocare Technologies FCF Margin % Historical Data

The historical data trend for Thyrocare Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies FCF Margin % Chart

Thyrocare Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.38 17.80 12.83 16.26 18.54

Thyrocare Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Thyrocare Technologies's FCF Margin %

For the Diagnostics & Research subindustry, Thyrocare Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's FCF Margin % falls into.



Thyrocare Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Thyrocare Technologies's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=1060.3/5718.8
=18.54 %

Thyrocare Technologies's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=0/1542.5
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thyrocare Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies (NSE:THYROCARE) Business Description

Traded in Other Exchanges
Address
D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines